Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan
Journal of Infection and Public Health · 2025
DOI: 10.1016/j.jiph.2025.102760 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Fu-Der Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Institute of Public Health, Nat…. Hauptthemen laut MEDLINE: Ritonavir, COVID-19 Drug Treatment, COVID-19, Antiviral Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Institute of Public Health, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Internal Medicine, Shuang Ho Hospital, New Taipei City, Taipei Medical University, Taipei, Taiwan.
- Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei City, Taiwan; Clinical Data Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan; Clinical Big Data Resea…
Förderung
- National Science and Technology Council
Zitieren
APA
Wang, F. D., Chang, Y. H., Chuang, H. C., Ou, T. Y., Lee, M. H., Nguyen, P. A., Phan, T. P., Burton, W., Nguyen, T. K. H., Hsu, M. H., Lin, S. M., Yang, C., & Hsu, J. C. (2025). Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102760
Vancouver
Wang FD, Chang YH, Chuang HC, Ou TY, Lee MH, Nguyen PA, et al. Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102760
BibTeX
@article{Wang2025,
author = {Wang, Fu-Der and Chang, Yu-Hui and Chuang, Han-Chuan and Ou, Tsong-Yih and Lee, Mei-Hui and Nguyen, Phung-Anh and Phan, Thanh Phuc and Burton, Whitney and Nguyen, Thi Kim Hien and Hsu, Min-Huei and Lin, Shiue-Ming and Yang, Chieh and Hsu, Jason C},
title = {Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan},
journal = {Journal of Infection and Public Health},
year = {2025},
doi = {10.1016/j.jiph.2025.102760}
}
EUVIMED